A number of stocks fell in the afternoon session after Federal Reserve Chair Jerome Powell signaled a cautious stance on ...

HIMS has experienced similar dramatic drops before. During the 2022 inflation surge, the stock fell 87%, and in 2020, it ...

We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on wallstreetbets Subreddit Page by MostCapital5741. In ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

One of the best players in the Los Angeles Lakers, Luka Doncic, is having a great moment with the team and his head coach JJ ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

Teladoc stock has declined significantly, from a high of $14 per share in February to $7 per share. Read why I downgrade TDOC ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cencora (COR – Research Report) and Johnson ...

Compounding Pharmacies Market Size and GrowthThe global compounding pharmacies market was worth USD 13.23 billion in 2024 and ...

Elevance Health, Inc. ELV is scheduled to release first-quarter 2025 results on April 22, before the opening bell. The Zacks ...

The United States market has shown a robust performance recently, climbing 8.4% in the last week and increasing by 5.9% over the past year, with earnings anticipated to grow by 13% annually. In this ...